Given the fundamental principle that cancer must arise from a cell that has the potential to divide, two major nonexclusive hypotheses of the cellular origin of cancer are that malignancy arises a) from stem cells due to maturation arrest or b) from dedifferentiation of mature cells that retain the ability to proliferate. The role of stem cells in carcinogenesis is clearly demonstrated in teratocarcinomas. The malignant stem cells of teratocarcinomas are derived from normal multipotent stem cells and have the potential to differentiate into normal benign mature tissue. A widely studied model supporting dedifferentiation has been the putative origin of hepatocarcinomas from "premalignant" foci and nodules induced in the rat liver by chemicals. However, the dedifferentiation concept for hepatocarcinogenesis is challenged by more recent interpretations indicating that hepatocellular carcinoma arises from maturation arrest caused by abherrant differentiation of determined stem cells. Either hypothesis is supported by the cellular changes that occur in the rodent liver after different hepatocarcinogenic regimens. The formation of foci and nodules from altered hepatocytes supports dedifferentiation; the proliferation of small oval cells with the potential to differentiate into either biliary ducts or hepatocytes supports arrested maturation of determined stem cells. It is now postulated that foci and nodular change reflect adaptive changes to the toxic effects of carcinogens and not "preneoplastic" stages to cancer. The stem cell model predicts that genotoxic chemicals induce mutations in the determined stem cell which may be expressed in its progeny. Proliferation of initiated cells is induced by promoting events which also allow additional mutations to occur.
Introduction
Although analysis of carcinogenic events by modern techniques of molecular oncology has greatly increased our understanding of how malignant transformation may occur, there are still basic questions concerning the cellular process from which cancer arises. Given the fundamental principle that cancer cannot arise in terminally differentiated cells but must arise from a cell that has the potential to divide, there are two possibilities: tumors arise from dedifferentiation of mature cells or from maturation arrest of immature stem cells.
Embryonal Theory of Cancer
The "stem cell" or embryonal origin of cancer may have been the first generally accepted theory of the etiology of cancer (1) . The embryonal rest theory of cancer has been attributed to Cohnheim (2) . He proposed that cancers arose from displacement of embryonic cells. At some stage of embryonic life, cells become isolated or fixed while they still possess great energy. These cells normally become differentiated in the adult, but because of their isolation they manifest embryonic capacity for continued growth in the adult. Rippert (3) expanded the embryonic rest theory to include the possibility that cells expressing embryonic potential for growth could arise in the adult (dedifferentiation). However, Rotter (4) proposed that primitive sex cells might lodge anywhere outside the ultimate sex glands during development and serve as the origin of tumors. He also thought that the growth of epithelial tumors depended on primary changes in the underlying connective tissue, which allowed invasion and expansive growth of epithelium.
With the identification of cell-free filtrates (5) and exogenous chemicals (6) that could cause cancer, the idea that an infectious event caused dedifferentiation of mature cells to form cancers became more popular. The more recently developed concept of infection with oncogenic viruses or of activation of proto-oncogenes (7, 8) as the causative events in cancer has been explained by action of oncogene products on adult cells causing transformation to malignant phenotype (dedifferentiation). This explanation is supported by the observation that transfection or activation of oncogenes can cause proliferative changes in apparently mature cells in tissue culture. However, the process of carcinogenesis in vivo includes proliferation of less differentiated cells, and cell lines in culture always contain a certain fraction of proliferating cells that may represent determined stem cells.
Stem Cell Tumors
The similarity of histologic appearance and growth characteristics between embryonic tissues and cancer is a major observation that supports the concept of a stem cell origin of cancer. In particular, the characteristics of teratocarcinomas, which produce a variety of undifferentiated as well as fully differentiated cells, are more consistent with a stem cell origin than dedifferentiation (9) . Teratocarcinomas contain structures resembling presomite embryos (embryoid bodies) intermixed with virtually every recognizable fetal and adult tissue (10, 1 1). Pierce et al. (12) showed that teratocarcinomas (embryonal carcinomas) not only contained malignant presomatic cells, but also included benign somatic tissue. In addition, the ability of transplantable teratocarcinomas of mice to differentiate into mature benign cells provides irrefutable evidence for the stem cell origin of this form of cancer (13) .
Transplantable teratocarcinomas were first produced by Stevens (14) by injecting the cells from the genital ridge of F1 mice into the testicles of parental mice. The normal genital-ridge cells grew in the testes and gave rise to solid teratocarcinomas that have now been passed for over 200 generations in inbred parental mice (Fig. 1) . When growing in the recipient mouse, proliferating, malignant, transplantable teratocarcinoma cells differentiate into benign cells located in well-differentiated keratin pearls within the tumor (16) . Transplantation of the tumor-producing core cells of malignant teratocarcinomas into normal blastocysts may result in birth of normal differentiated adult cells (17) (18) (19) . Labeled embryonal-carcinomal cells localize preferentially in the mural trophectoderm of the blastocyst, in the primitive endoderm, and rarely in the inner cell mass. The carcinoma cells differentiate into differentiated cells in accordance with their localization (20) Is There a Liver Stem Cell?
The question of whether there is a liver stem cell was posed in a recent review (22) . The 
Carcinogen-Induced Oval Cell Proliferation
The effects of five carcinogenic regimens that show different kinetics of oval cell production, foci and nodule formation, and serum AFP elevations are compared in Table 2 and Figure 4 . AFP is a serum protein found at high levels in fetal serum that becomes re-elevated in adults after liver proliferation or development of HCC (20, 59, 60) . In our studies serum AFP levels were used to determine liver cell or oval cell proliferation early after carcinogen exposure, mitogen treatment (including partial hepatectomy), and necrotic liver injury, as well as development of liver cell cancer later after carcinogen treatment (Fig. 5) . In recombinant, inbred mice, serum AFP may be used to predict which animals develop adenomas or HCC and to select animals for morphologic examination (61, 62 (55, 56) . 1990-Sell proposes that liver stem cell may be either periportal cell or transition duct cell (21) .
vation of serum AFP, it became clear that serum AFP became elevated before nodules appeared and that the cells containing AFP were oval cells and not foci or nodules (43) (44) (45) (46) (47) . From these observations it was tentatively concluded that HCC might not arise from foci and nodules but from oval cells (Fig. 6) .
A study of the early cellular events with dimethylnitrosamine (DEN) was most revealing regarding the cellular lineage of HCC (56 (27) . WY-14643 stimulates peroxisome proliferation and is a nongenotoxic mitogen (67, 68) Figure 6 . Morphologic changes and serum a-fetoprotein (AFP) levels during cyclic feeding of a-acetylaminofluorene (AAF). After four 2-weeks-on/1-week-off cycles of feeding AAF (a total of 12 weeks), rats develop one or sometimes two hepatocellular carcinomas 24 weeks later. After each AAF feeding the livers of the rats contain a progression of lesions from small foci of basophilic hepatocytes to larger eosinophilic foci to nodules of increasing size that distort the liver. If the fourth cycle is not fed, all of the changes are reversible, However, after the fourth cycle most of the nodules still disappear ("remold"), but hepatocellular carcinoma (HCC) develops 24 weeks later from what appear to be persistent nodules that do not regress (64) . The progressive histologic and enzymatic changes in the foci and nodules preceding the appearance of HCC led a number of investigators to conclude that foci represent initiated hepatocytes that may be selected by further treatment to express the malignant phenotype (32) (33) (34) (35) (36) (51) . The relationships of these cell types is illustrated in Figure 7 . Earlier autoradiographic studies implicated terminal bile duct cells as the precursors of oval cells (40, 41) . However, the conclusion that oval cells come from duct cells was based on autoradiographic studies done several weeks after carcinogen exposure (41, 74) . Using autoradiography during the first 3 days after CD-AAP, the majority of the proliferating-cell population was identified as a periportal cell, whereas after 3 days, labelling increased in the duct cell population (50) . These early labeled cells were identified by electron microscopy as small periportal cells, and later duct cells, in particular, transition duct cells (22, 51) .
HEPATOCYTES TRANSITION
Later, when oval-cell proliferation is at a peak, many of the oval cells infiltrating the liver cords are transition duct cells (41) . It is possible that both the transition duct cell and a periportal-liver-determined stem cell have the potential to proliferate and differentiate into duct or liver cells. Which cell is predominant may depend on the degree of carcinogen stimulation or liver cell injury. The greater the stimulus, the more likely it is to involve the less differentiated periportal cell.
Bile Duct Proliferation
An argument against the terminal bile duct as the liver stem cell is that stimulation of bile duct proliferation per se does not result in hepatocarcinogenesis (42) . Agents that selectively stimulate bile duct proliferation do not induce oval-cell proliferation. Induction of bile duct hyperplasia by nonhepatocarcinogens such as bile duct ligation, 4,4'-diaminodiphenylmethane (DDPM), or a-naphthylisothiocyanate (ANIT) do not induce AFP or albumin-containing duct cells (75) (76) (77) . There is one report identifying AFP-containing bile duct cells after ANIT (78) , but this was not found in our studies (75, 76 (50, 75, 76) . Thus, there appear to be two distinct types of ductlike cell proliferation (80) : one is nonmalignant proliferation of bile ducts, the other proliferation of duct-like oval cells that have the potential to produce malignant tumors in the liver cell lineage.
Liver Stem Cell and Restitutive Proliferation
One of the properties of determined stem cells is to restore amputated or damaged tissue. For example, the stem cell for the limb of the amphibian is able to regenerate to form a normal limb after amputation, but it cannot form other organs (81) . The presence of a liver stem cell has been questioned in the past because it did not appear that a liver stem cell was required for regeneration of the liver (Fig. 2) . After PH or chemical injury (CCl4, galactosamine) the liver deficit is replaced by proliferating hepatocytes that are derived from adult hepatocytes (82) (83) (84) (85) (86) . For example, after two-third PH of the rat, each hepatocyte in the remaining lobes divides once or twice within a 48-hr period, without involvement of a stem cell (83, 84, 86, 87) . In fact, AFP can be identified in large, dividing hepatocytes after PH in the rat (88) and adjacent to zones of liver injury after CCl4 injury in the mouse (59) .
However, with more severe liver injury, a liver stem cell may be called upon to restore the liver. For example, after severe injury with CCl4, Engelhardt et al (89) found some small ovallike cells contained AFP, a marker for proliferation, and Petropoulos et al. (90) 
Stem Cells in Developing Liver
Determined stem cells are also the precursors for normal adult cells in developing organs (13) . In the liver of the developing rat fetus, cells have been identified that have the characteristics of the oval cells seen in the adult (53, 58, 88, (92) (93) (94) (101) indicates that there is a common stem cell for liver, biliary ducts, and pancreas. Thus, there appears to be a determined stem cell in the fetus that gives rise to pancreas and liver.
Role of Stem Cells in Normal Liver Cell Turnover
There is some evidence that the cells that make up the hepatic cords are replaced by proliferating cells that originate in the portal area and migrate to the central zone, where they terminally differentiate and are removed by apoptosis (102) (103) (104) . It is proposed that the heptocytes are formed at the periportal tract rim, where determined stem cells interact with ductal and stromal elements. The assembled unit then streams across the three acinar zones until it reaches the terminal hepatic vein where it is eliminated. The liver unit replaces itself in a manner similar to, but much slower than, the layered epithelium of the skin or bladder and the gastrointestinal tract (Fig. 8) . In the skin, stem cells located in the basal layer of skin divide to produce daughter cells, one of which differentiates and migrates to the next layer and eventually terminally differentiates into a non-nucleated squamous cell (28, 105, 106) . A steady number of gastrointestinal lining cells is maintained by a balance of cells proliferating in the lower levels of the epithelium to those differentiating in the mid-level of the epithelium and exfoliated at the surface (107, 108 
Lasting Effect of Initiation
One of the principles of initiation is that once a genotoxic event occurs, it will persist essentially for the lifetime of the animal (112, 113 Hepatitis B, Hepatocellular Proliferation, and Hepatocellular Carcinoma
The incidence of cancer in different organs is closely related to the rate of cell turnover (118) . The incidence of cancer of the skin and gastrointestinal tract is much higher than that of the liver in the western world. However, in areas of the world where hepatitis B is endemic and infected individuals have a marked increased turnover of liver cells related to liver damage, HCC is the most common cancer (119, 120) . The association of a higher incidence of HCC with hepatitis B infection is most likely related to the increased turnover of liver cells secondary to destruction of liver cells, leading to stimulation of proliferation of stem cells and other cells early in the liver acinus dedifferentiation proliferation (121) . Similarly, increased restitutive proliferation in cirrhosis is also associated with increased incidence of HCC (111, 123) . This increased liver cell turnover increased the likelihood of endogenous carcinogenesis because of the increased chance for mutations (108) . In transgenic mice expressing hepatitis B viral (HBV) proteins, liver cancer has developed both with and without preceding liver cell damage (124-130; 
